The concentration of IL-6 was higher in the serum of patients with ovarian cancer compared to benign ovarian masses or normal ovaries (median IL-6: 28.3 vs. 6.4 vs. 1.2 pg/mL, p < 0.0001) (Figure 4). The gene discussed is IL6; the disease is ovarian cancer.